GYRE Competitors & Alternatives
Compare Gyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
GYRE
Main Stock$5.82
Tradestie Score
54
Market Cap
$688.47M
Revenue Growth
0.0%
Analyst Upside
+220.7%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$13.38
|
$626.91M | - | 53 | Compare |
|
SVRA
Savara Inc.
|
$5.30
|
$611.84M | - | 62 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$2.93
|
$552.46M | - | 54 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$11.74
|
$540.97M | - | 53 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$12.65
|
$529.35M | 6.2 | 63 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.95
|
$512.39M | - | 54 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$32.46
|
$505.12M | 1.7 | 65 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$93.11
|
$492.21M | - | 49 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.78
|
$474.20M | 26.7 | 59 | Compare |
More GYRE Analysis
Data updated: Jun 17, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry